Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Washington Awards AbbVie Nation’s Second ‘Netflix’ Hep-C Contract

  • Post author:Sam
  • Post published:April 29, 2019
  • Post category:Drug Industry Daily

Washington state regulators have awarded AbbVie an exclusive contract to help the state rid itself of Hepatitis C within the next decade—the nation’s second state to adopt a subscription payment…

Continue ReadingWashington Awards AbbVie Nation’s Second ‘Netflix’ Hep-C Contract

WHO Issues Urgent Call for New Drugs to Fight Superbugs

  • Post author:Sam
  • Post published:April 29, 2019
  • Post category:Drug Industry Daily

Drugmakers and regulators urgently need to create a pipeline of drugs to treat the growing threat of antibiotic-resistant diseases, the World Health Organization says in a new report issued Monday.…

Continue ReadingWHO Issues Urgent Call for New Drugs to Fight Superbugs

Cincinnati Drugmaker Cited for Quality, Equipment Concerns

  • Post author:Sam
  • Post published:April 26, 2019
  • Post category:Drug Industry Daily

The FDA hit Patheon Pharmaceuticals with a Form 483 for equipment and quality violations at its Cincinnati, Ohio facility. Source: Drug Industry Daily

Continue ReadingCincinnati Drugmaker Cited for Quality, Equipment Concerns

Oklahoma OTC Manufacturer Cited for Multiple Violations

  • Post author:Sam
  • Post published:March 29, 2019
  • Post category:Drug Industry Daily

The FDA hit OTC drug manufacturer Tomco-Harwel Industries with an extensive Form 483 for numerous violations at its Tulsa, Oklahoma facility. Source: Drug Industry Daily

Continue ReadingOklahoma OTC Manufacturer Cited for Multiple Violations

FDA Warns California OTC Drugmaker for Defective Products

  • Post author:Sam
  • Post published:March 29, 2019
  • Post category:Drug Industry Daily

The FDA issued a warning letter to Thibiant International for producing defective OTC drugs at its Newbury Park, California manufacturing facility. Source: Drug Industry Daily

Continue ReadingFDA Warns California OTC Drugmaker for Defective Products

Brexit Chaos Has Drug Regulators, Industry Living in Conditional Tense

  • Post author:Sam
  • Post published:March 29, 2019
  • Post category:Drug Industry Daily

UK lawmakers on Friday failed to approve an orderly withdrawal from the European Union, leaving drugmakers and regulators scrambling to make sense of the chaos. Source: Drug Industry Daily

Continue ReadingBrexit Chaos Has Drug Regulators, Industry Living in Conditional Tense

Gottlieb Urges Drug Sponsors to Expand Access to Treatment After Trials

  • Post author:Sam
  • Post published:March 29, 2019
  • Post category:Drug Industry Daily

FDA Commissioner Scott Gottlieb and two of his top aides took to the internet Friday to urge drug sponsors to continue treatment for especially needy clinical trial patients after their…

Continue ReadingGottlieb Urges Drug Sponsors to Expand Access to Treatment After Trials

EMA Reviews Two Decades of Drug Inspections

  • Post author:Sam
  • Post published:March 28, 2019
  • Post category:Drug Industry Daily

EU regulators flagged 18 percent of inspected biologics and nine percent of inspected drugs for scientific or regulatory problems in the two decades since European regulators began inspecting drugs and…

Continue ReadingEMA Reviews Two Decades of Drug Inspections

New York Files Detailed Suit Against Opioid Makers, Distributors

  • Post author:Sam
  • Post published:March 28, 2019
  • Post category:Drug Industry Daily

New York’s Attorney General Letitia James on Thursday joined the opioid fray accusing drugmakers and distributors—including Purdue Pharma and its owners, the Sackler family—of unleashing a “plague” that has killed…

Continue ReadingNew York Files Detailed Suit Against Opioid Makers, Distributors

Gottlieb Highlights FDA Efforts on Opioids in Senate Testimony

  • Post author:Sam
  • Post published:March 28, 2019
  • Post category:Drug Industry Daily

It was a lovefest for outgoing FDA Commissioner Scott Gottlieb on Thursday as he testified before the Senate Committee on Appropriations on the FDA’s budget request for fiscal 2020. Source:…

Continue ReadingGottlieb Highlights FDA Efforts on Opioids in Senate Testimony
  • Go to the previous page
  • 1
  • …
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • …
  • 385
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.